Since the late 1990s, few areas of science have been able to compete with genetics when it comes to attracting public interest. The mapping of the entire human gene pool, the Hugo project, makes clear that genetics and gene technology concern life itself. The analysis of the human DNA means that new medicines can be designed, but also that human genetic material can be patented and commercialized. In this volume scholars shed light on the links between biotechnology and economics from a multidisciplinary perspective. Patent on genes, national and global power (im)balance, as well as human and plant genomics, are discussed.